There is a consensus among experts in cancer pain management pharmacy.

Guide Name: Cancer Pain Management Pharmacy Expert Consensus English Title: Publisher: Beijing Pain Treatment Quality Control and Improvement Center Cancer Pain Expert Group Release Date: 2019-11-30 Summary: Cancer pain pathogenesis is complex, clinical manifestations are diverse, treatment effects of many factors, the formation of multidisciplinary pain management team has become a broad consensus.
pharmaceutical department occupies a very important position in the standard use and management of cancer pain treatment drugs, and its work involves all aspects of pharmaceutical management and pharmaceutical services.
In order to give full play to the role of pharmaceutical professional and technical personnel in the process of cancer pain drug treatment, combined with the current situation of cancer pain treatment in China, this consensus is formulated with a view to providing guidance for the practice of pharmaceutical services to promote the standardized management of cancer pain.
Expanded Guidelines: Cancer-Related Guidelines: 2019 ACOG Committee Opinion: Genetic Cancer Syndrome and Risk Assessment (No.793) 2019 COSA Position Statement: Cancer Survivor Care International Union (FIGO) 2018 Cancer Report: Guidelines for the Diagnosis and Treatment of Endometrial Cancer Interpreting NCCN Clinical Practice Guidelines: Cancer-Related Fatigue (2019.V2) 20 19 International Multidisciplinary Roundtable Consensus Statement: More information on the Cancer Survivors Campaign Guide Click: More guidelines on cancer Source: Chinese Journal of Pain Medicine. 2019, 25 (11): 801-807. Download the Macy's Medical APP Download (Mess Medical APP Points Download) Tip: 78% of users have downloaded The Mace Medical APP for easy reading and communication, please scan the two-dimensional code to download the APP directly.